Skip to main
BCPC

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Balchem is in a strong position with solid financial metrics, including significant cash flow from operating activities and a low net debt leverage ratio. The company's diversified segments and global reach position it well for continued growth, as indicated by its record sales and in-line revenue and earnings. Additionally, potential increased demand for its choline ingredient, particularly in the aging population, could support continued growth and improve its valuation. However, risks such as slower growth, inflationary pressures, and potential disruptions in its European markets should also be considered.

Bears say

Balchem is facing challenges in maintaining its margins while competition and raw material inflation put pressure on its profitability. With modest revenue misses and earnings in line, and a declining P/E multiple, the company's expected revenue growth may not be enough to support the current stock price. Additionally, the potential impact of geopolitical events on demand for Balchem's industrial products is uncertain, making it difficult to predict future performance.

Balchem (BCPC) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Buy based on their latest research and market trends.

According to 2 analysts, Balchem (BCPC) has a Buy consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.